Vitamin D3 for Life

Live Enlightened

Article

VDR Tissue Distribution and Measurement Reliability: Evidence Synthesis

Previous related pageVDR FokI, Receptor Expression and Linked Haplotypes: Evidence SynthesisNext related pageVDR Variants, Receptor Activity and Gene Regulation: Full Evidence Review
Study at a glance

Where is the vitamin D receptor found?

The vitamin D receptor is a protein that helps cells respond to active vitamin D. It is found in many tissues, including the intestine, kidneys, bone and skin. Its amount varies between tissues and between different kinds of cells within the same organ.

Why do studies disagree about where the receptor is present?

Tests differ in what they measure and how reliably they detect small amounts. Some measure receptor protein; others measure the genetic messages used to make it. A weak or missing signal does not always mean the receptor is absent, and a positive signal needs checks to show it really comes from the receptor.

Does finding the vitamin D receptor prove that vitamin D is working?

No. Receptor presence shows one part of the system is there. It does not establish that the receptor is receiving a signal or producing a response in that tissue.

Read the full article below ↓

Where the vitamin D receptor is expressed matters, but the question is more difficult than a simple tissue list suggests. VDR can be abundant in one cell population, sparse in another and below the detection threshold of a particular assay in a third. A scientifically useful map therefore has to combine distribution with measurement reliability.

VDR is broadly distributed, but not uniformly

The evidence supports broad VDR expression across classical calcium-regulating tissues and many non-classical targets. Bouillon and colleagues’ synthesis of VDR-null biology places the receptor across intestine, kidney, bone, parathyroid, skin and multiple other systems. The important qualification is that broad distribution does not mean uniform abundance, identical cell localisation or equal biological importance in every tissue.

Pike and colleagues reach the same broader conclusion from modern receptor biology: VDR is expressed in many cell types, yet its abundance and regulatory environment vary substantially. A statement that VDR is ‘everywhere’ loses exactly the information that makes tissue biology interesting.

Cell type can matter more than the organ label

An organ contains multiple cell populations. Detecting VDR somewhere in kidney, skin or pancreas does not establish that every cell in that organ expresses the receptor at the same level. Lee and colleagues used large genomic transgenes to reproduce tissue: and cell-specific VDR expression in mice. Their work showed strong expression in classical target tissues and much lower signals in some other tissues, while immunohistology resolved receptor expression within particular cell populations.

That distinction changes how distribution data should be read. ‘Kidney VDR’ is not a single homogeneous signal. Neither is ‘intestinal VDR’ or ‘skin VDR’. Cell-level localisation is necessary when the biological question concerns a particular epithelial, endocrine or follicular compartment.

Antibody specificity can change the apparent map

Measurement reliability is not an afterthought. Wang, Borchert and DeLuca examined VDR localisation in mouse kidney with a highly specific antibody and VDR-null tissue as a negative control. That knockout-control logic is especially valuable: if staining remains in tissue that genetically lacks VDR, the signal cannot simply be accepted as receptor localisation.

Their study illustrates a general rule for receptor mapping. Immunohistochemistry can be extremely informative, but apparent localisation depends on antibody specificity, tissue preparation, signal threshold and the presence of appropriate negative controls. Older or less specific reagents can produce broader-looking maps than a more selective assay.

Different methods answer different distribution questions

Western blotting, immunohistochemistry, reporter constructs and transcript measurements do not measure the same thing. A Western blot asks whether receptor protein can be detected in a bulk tissue extract. Histology asks where signal appears within tissue architecture. Reporter models can reveal regulatory activity at the VDR locus. RNA abundance measures transcription rather than receptor protein itself.

A negative result with one method can therefore mean several things: true absence, low abundance, restricted expression in a minority cell population, insufficient assay sensitivity or a mismatch between transcript and protein. This is why measurement method belongs inside the biological interpretation rather than being hidden in a methods footnote.

Presence does not equal active signalling

Even reliable detection establishes only that receptor is present. It does not show that ligand is available, that VDR occupies relevant genomic sites, that coregulators are recruited or that a physiological response follows. Receptor presence is one prerequisite within a longer signalling chain.

That distinction is developed further in Why VDR Presence Is Not the Same as Vitamin D Response. For receptor abundance and turnover, see VDR Abundance, Regulation and Receptor Turnover. For causal evidence about what receptor function in a specific tissue actually does, see Tissue-Specific VDR Physiology: Knockout and Rescue Evidence.

How to interpret tissue-distribution claims

The most defensible interpretation is therefore layered. VDR has a broad tissue distribution, but expression is heterogeneous between tissues and between cell types within tissues. The apparent map is also assay-dependent. Strong localisation claims deserve stronger evidence when receptor abundance is low or cell-restricted, ideally including genetic negative controls or convergent methods.

This prevents two opposite errors. One is to treat failure to detect VDR as proof that no biologically relevant receptor exists. The other is to treat any positive staining signal as proof of robust functional signalling. The evidence supports neither shortcut.

The central interpretation

VDR distribution is real but conditional: conditional on tissue, cell type, receptor abundance and the measurement system used to find it. The strongest evidence combines broad physiological mapping with cell-specific localisation and assay controls. That produces a more accurate picture than either an unqualified ‘ubiquitous receptor’ claim or an overly narrow list of classical target organs.

Return to Vitamin D Receptors for the wider receptor framework.

Primary evidence used in this synthesis

  • Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.
  • Identification of the vitamin D receptor in various cells of the mouse kidney · Yongji Wang, Rachael L Borchert, Hector F DeLuca. PMID 22278022; PMCID PMC3343313; DOI 10.1038/ki.2011.463.
  • Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.
  • The vitamin D receptor: contemporary genomic approaches reveal new basic and translational insights · J. Wesley Pike, Mark B. Meyer, Seong-Min Lee, Melda Onal, Nancy A. Benkusky. PMID 28240603; PMCID PMC5373853; DOI 10.1172/JCI88887.

Related reading

Original sources

Source

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay.

Publication details

Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice · Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F Luderer, Liesbet Lieben, Chantal Mathieu, Marie Demay. PMID 18694980; PMCID PMC2583388; DOI 10.1210/er.2008-0004.

Read more →
Source

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A.

Publication details

Mouse and human BAC transgenes recapitulate tissue-specific expression of the vitamin D receptor in mice and rescue the VDR-null phenotype · Seong-Min Lee, Kathleen A. Bishop, Joseph J. Goellner, Charles A. O’Brien, J. Wesley Pike. PMID 24693968; PMCID PMC4020932; DOI 10.1210/en.2014-1107.

Read more →